Authors
- Ahmed Abdelsamie FadlPediatric senior registrar at Doctor Samir Abbas Hospital, Department of pediatrics, Alazhar University hospitals, Cairo.SCFHS number: 12JM0036858
- Almuthaybiri Musaad Masoud AGP, Riyadh Al Khabra hospital, Qassim, Saudi Arabia.
- Kabrah Lama Kamal STaif university, Taif ,Saudi Arabia.
- Assiri Amjad Abdullah HIntern, Ibn Sina National College, Jeddah, Saudi Arabia.
- Alahmadi Khalid Mohammed MIntern, Ibn Sina National College, Jeddah, Saudi Arabia.
- Yousra Bala Babkir Abd AllaPediatric resident, Najran armed force hospital, Pediatric and NICU department.
- Yassir Mohammed DarwishPediatric Department, Hera General Hospital, Makkah, Saudi Arabia.
- Mohammed Ali AlaamreePediatric resident, MOH, Sabt alayia hospital
- Ahmed Faroug Ahmed AbdelaalNajran Armed Forces Hospital, Pediatric and NICU department.
- Norah Sulaiman AljabarahGP, Maternity and Children Hospital, Hail, Saudi Arabia.
- Amaal Abdulrahman AlwayliArabian gulf university, Bahrain
- Badriah Helal AlazmiKing faisal hospital, Alqurayat, Saudi Arabia
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.SP2.L19-L24Keywords:
Hepatic Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy, Liver FailureAbstract
Abstract: Fulminant hepatic failure FHF in children is a rare but often fatal condition. Our understanding of this disorder is limited due to the disorder's rarity. The majority of FHF cases in children have no known cause. The mechanisms by which hepatocytes undergo cell death are unknown. The aetiology and degree of CNS involvement influence the outcome. The study aims to summarize current evidence on the prevalence, risk factors and management approaches of irritable bowel syndrome in Saudi Arabia. For article selection, the PubMed database and EBSCO Information Services were used. All relevant articles relevant to our topic and other articles were used in our review. Other articles that were not related to this field were excluded. The data was extracted in a specific format that the group members reviewed. Seven studies were included and affirmed that mortality of fulminant hepatic failure is high, and the commonest aetiology is viral infections, particularly HAV. The peak level of total serum bilirubin, the rate of change of the prothrombin time/daily and ammonia level were significant predictors of mortality.
References
Wang L, Zhang D, Fan C, Zhou X, Liu Z, Zheng B, Zhu L, Jin Y. Novel Compound Heterozygous TMPRSS15 Gene Variants Cause Enterokinase Deficiency. Front Genet. 2020 Sep 11;11:538778. doi: 10.3389/fgene.2020.538778. PMID: 33061943; PMCID: PMC7517701.
Holzinger A., Maier E. M., Bück C., Mayerhofer P. U., Kappler M., Haworth J. C., et al. (2002). Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropep.
Ghishan F. K., Lee P. C., Lebenthal E., Johnson P., Bradley C. A., Greene H. L. (1983). Isolated congenital enterokinase deficiency. Recent findings and review of the literature. Gastroenterology 85 727–731. 10.1016/0016-5085(83)90033-1
Eggermont E, Molla AM, Tytgat G, Rutgeerts L (1971) Distribution of enterokinase activity in the human intestine. Acta Gastroenterol Belg 34:655–662.
Zamolodchikova TS, Sokolova EA, Lu D, Sadler JE (2000) Activation of recombinant proenteropeptidase by duodenase. FEBS Lett 466:295–299.
Yang X, Yin H, Peng L, Zhang D, Li K, Cui F, Xia C, Huang H, Li Z. The Global Status and Trends of Enteropeptidase: A Bibliometric Study. Front Med (Lausanne). 2022 Feb 10;9:779722. doi: 10.3389/fmed.2022.779722. PMID: 35223895; PMCID: PMC8866687.
Austin AE. Enterokinase in infancy. J Med Res. (1909) 20:137–47.
Babcock SJ, Flores-Marin D, Thiagarajah JR. The genetics of monogenic intestinal epithelial disorders [published online ahead of print, 2022 Nov 23]. Hum Genet. 2022;10.1007/s00439-022-02501-5. doi:10.1007/s00439-022-02501-5
Grant D. Acute necrotising pancreatitis - a role for enterokinase. Int J Pancreatol. (1986) 1:167–83. 10.1007/BF02795243.
Kitamoto Y, Yuan X, Wu Q, McCourt DW, Sadler JE. Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proc Natl Acad Sci USA. (1994) 91:7588–92. 10.1073/pnas.91.16.7588.
Light A, Savithri HS, Liepnieks JJ. Specificity of bovine enterokinase toward protein substrates. Anal Biochem. (1980) 106:199–206. 10.1016/0003-2697(80)90138-4.
Montoro-Huguet MA, Belloc B, Domínguez-Cajal M. Small and Large Intestine (I): Malabsorption of Nutrients. Nutrients. 2021 Apr 11;13(4):1254. doi: 10.3390/nu13041254. PMID: 33920345; PMCID: PMC8070135.
Rashid MY, Noor A, Patel V, Henin S, Cuello-Ramírez A, Al Kaabi AS, Gnawali A, Mostafa JA. Role of SCO-792, A Novel Enteropeptidase Inhibitor, In the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Cureus. 2021 Mar 5;13(3):e13724. doi: 10.7759/cureus.13724. PMID: 33833935; PMCID: PMC8018875.
Haworth JC. Malabsorption and Growth Failure Due to Intestinal Enterokinase Deficiency. J Pediatr 1971;78:481-90.
Agostino Nocerino, Stefano Guandalini: Intestinal Enterokinase Deficiency. Medscape. 2017 https://emedicine.medscape.com/article/930249
Zoppi G, Andreotti G, Pajno-Ferrara F, Njai DM, Gaburro D. Exocrine pancreas function in premature and full term neonates. Pediatr Res. (1972) 6:880–6. 10.1203/00006450-197212000-00005 [PubMed] [CrossRef] [Google Scholar]
Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al.. Identification of the cystic fibrosis gene: genetic analysis. Science. (1989) 245:1073–80. 10.1126/science.2570460 [PubMed] [CrossRef] [Google Scholar]
Elborn JS. Cystic fibrosis. Lancet. (2016) 388:2519–31. 10.1016/S0140-6736(16)00576-6 [PubMed] [CrossRef] [Google Scholar]
Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, et al.. ECFS best practice guidelines: the 2018 revision. J Cyst Fibros. (2018) 17:153–78. 10.1016/j.jcf.2018.02.006 [PubMed] [CrossRef] [Google Scholar]
Myers KC, Bolyard AA, Otto B, Wong TE, Jones AT, Harris RE, et al.. Variable clinical presentation of shwachman-diamond syndrome: update from the north american shwachman-diamond syndrome registry. J Pediatr. (2014) 164:866–70. 10.1016/j.jpeds.2013.11.039 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Hill RE, Durie PR, Gaskin KJ, Davidson GP, Forstner GG. Steatorrhea and pancreatic insufficiency in shwachman syndrome. Gastroenterology. (1982) 83:22–7. 10.1016/S0016-5085(82)80279-5 [PubMed] [CrossRef] [Google Scholar]
Shteyer E, Saada A, Shaag A, Al-Hijawi FA, Kidess R, Revel-Vilk S, et al.. Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene. Am J Hum Genet. (2009) 84:412–7. 10.1016/j.ajhg.2009.02.006 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Zenker M, Mayerle J, Lerch MM, Tagariello A, Zerres K, Durie PR, et al.. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-blizzard syndrome). Nat Genet. (2005) 37:1345–50. 10.1038/ng1681 [PubMed] [CrossRef] [Google Scholar]
Vanlieferinghen PH, Borderon C, Francannet CH, Gembara P, Dechelotte P. Johanson-blizzard syndrome. A new case with autopsy findings. Genet Couns. (2001) 12:245–50. [PubMed] [Google Scholar]
Voldsgaard P, Kryger‐Baggesen N., Lisse I. Agenesis of pancreas. Acta Paediatr 1994;83(7):791–793.
66 Lebenthal E, Antonowicz I, Shwachman H. Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine. Gastroenterology 1976;70(4):508–512. 67 Holzinger A et al. Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency. Am J Hum Genet 2002;70(1):20–25
Itoh S, Ikeda M, Ota T, Satake H, Takai K, Ishigaki T. Assessment of the pancreatic and intrapancreatic bile ducts using 0.5-mm collimation and multiplanar reformatted images in multislice CT. Eur Radiol. 2003;13:277–285.
Kozu T, Suda K, Toki F. Pancreatic development and anatomical variation. Gastrointest Endosc Clin N Am. 1995;5:1–30.
Quest L, Lombard M. Pancreas divisum: opinio divisa. Gut. 2000;47:317–319.
Schulte SJ. Embryology, normal variation, and congenital anomalies of the pancreas. In: Stevenson GW, Freeny PC, Margulis AR, Burhenne HJ, eds. Margulis’ and Burhenne’s alimentary tract radiology, 5th ed. St. Louis: Mosby, 1994:1039-1051
Sandrasegaran K, Patel A, Fogel EL, Zyromski NJ, Pitt HA. Annular pancreas in adults. AJR Am J Roentgenol. 2009;193:455–460.
Thoeni RF, Gedgaudas RK. Ectopic pancreas: usual and unusual features. Gastrointest Radiol. 1980;5:37–42
Chak A, Canto MI, Rösch T, Dittler HJ, Hawes RH, Tio TL, Lightdale CJ, Boyce HW, Scheiman J, Carpenter SL, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc. 1997;45:468–473.
Ayantunde AA, Pinder E, Heath DI. Symptomatic pyloric pancreatic heterotopia: report of three cases and review of the literature. Med Sci Monit. 2006;12:CS49–CS52.
Lerner A: Hereditary abnormality of the pancreas. In Lebenthal E (ed): Textbook of Gastroenterology and Nutrition in Infancy. New York, Raven Press, 1989, pp 877-883
Lemer A, Lebenthal E: Hereditary disease of the pancreas. In Go VLW, Dimagno El’, Gardner JD (eds): The Pancreas: Biology, Pathobiology, and Diseases. New York, Raven Press, 1993, pp 1083-1084
Lilja P, Evander A, Ihse I Hereditary pancreatitis-A report on two kindreds. Acta Chir Scand 14435-37, 1978
Loiudice JA, Lang J, Mehta H, et al: Treatment of acute alcoholic pancreatitis: The roles of cimetidine and nasogastric suction. Am J Gastroenterol 79:553-558, 1984
Wilschanski M, van der Hoeven E, Phillips J, et al: Shwachman-Diamond syndrome, presenting as hepatosplenomegaly. J Pediatr Gastroenterol Nutr 19:111-113, 1994
Woods WG, Roloff JS, Lukens GN, et al: The occurrence of leukemia in patients with the Shwachman’s syndrome. J Pediatr 99:425-428, 1981
Swischuk LE, Hayden CK Jr: Pararenal space hyperechogenicity in childhood pancreatitis. AJR 14510851086, 1985
Kiernan PD, ReMine SG, Kieman PC, et al: Annular pancreas: Mayo Clinic experience from 1957 to 1976 with review of the literature. Arch Surg 115:46-50, 1980
Isaksson G, Ihse I Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 28:97-102, 1983
Elitsur Y, Hunt JA, Chertow BS: Hereditary pancreatitis in the children of West Virginia. Pediatrics 93:528-531, 1994
Demeocq F, Storme 8, Schaison G, et al: Anemie refractaire sideroblastique avec vacuolisation des precurseurs medullaires et deficit de la function exocrine du pancreas. Arch Fr Pediatr 40:631-635, 1983
Hadorn B., Haworth J. C., Gourley B., Prasad A., Troesch V. (1975). Intestinal enterokinase deficiency. Occurrence in two sibs and age dependency of clinical expression. Arch. Dis. Child. 50 277–282. 10.1136/adc.50.4.277 .
Domínguez-Muñoz JE. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?. Adv Med Sci. 2011. 56(1):1-5.
Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, Figueiras A, Vilariño-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2005 Apr 15. 21(8):993-1000.
Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792. Sasaki M, Miyahisa I, Itono S, et al. Pharmacol Res Perspect. 2019;7:517.
Intestinal enterokinase deficiency. Hadorn B, Tarlow MJ, Lloyd JK, Wolff OH. Lancet. 1969;293:812–813.